# Cancer Center Support Grant - Early Career Cancer Clinical Investigator Award (ECIA)

> **NIH NIH P30** · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2024 · $60,000

## Abstract

PROJECT SUMMARY
This application is being submitted in response to the National Cancer Institute (NCI) Early Career
Cancer Clinical Investigator Award (ECIA) P30 Administrative Supplement for Fiscal Year (FY) 2024.
The Herbert Irving Comprehensive Cancer Center (HICCC) was designated as a National Cancer Institute
(NCI) Cancer Center in 1972 and gained comprehensive status in 1979. The HICCC is the critical driver of
cancer scientific research, clinical trials, innovative patient care, cancer education and training and community
outreach at Columbia University's Irving Medical Center (CUIMC) and NewYork-Presbyterian Hospital (NYPH).
During the current project period (2014-present), CUIMC and NYPH committed $415M for the following: (1)
new research initiatives in basic, translational, clinical and population sciences with >50 strategic faculty
recruitments; (2) new and expanded facilities for laboratory research, dry bench research and clinical activities;
(3) major faculty recruitments; and, (4) support of the HICCC's administrative core. A major aspect was the
recruitment of Anil K. Rustgi, MD as the HICCC Director in late 2018. Rustgi has the unequivocal authority over
cancer research space and cancer care facilities and accompanying substantial resources through the
transformative Irving Family Trust Gift, further reinforced through his dual roles as Associate Dean of Oncology
(CUIMC) and Chief of Cancer Services (NYPH). Over this project period, there was a greater focus upon
transdisciplinary cross-cutting scientific themes that catalyzed the restructuring of the scientific research
programs encompassing 175 members from 34 Departments and six Schools: Cancer Genomics and
Epigenomics; Tumor Biology and Microenvironment; Precision Oncology and Systems Biology; and, Cancer
Population Science. Importantly, Rustgi created units dedicated to Community Outreach and Engagement
(COE) and Cancer Research Career Enhancement (CRCE) and enhanced the 12 Shared Resources. The
Research Programs engendered impactful science with 3,399 publications of which 626 were intra-
programmatic and 456 were inter-programmatic. Total NCI funding is $26M and cancer-relevant funding is
$92M. The HICCC is requesting CCSG support of $4.1M per year (total DC) for the next project period.

## Key facts

- **NIH application ID:** 11002143
- **Project number:** 3P30CA013696-49S2
- **Recipient organization:** COLUMBIA UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** Anil K Rustgi
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $60,000
- **Award type:** 3
- **Project period:** 1997-07-04 → 2025-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11002143

## Citation

> US National Institutes of Health, RePORTER application 11002143, Cancer Center Support Grant - Early Career Cancer Clinical Investigator Award (ECIA) (3P30CA013696-49S2). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11002143. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*